Visualization of Intermetastatic Heterogeneity in Mixed Neuroendocrine Carcinoma-Acinar Adenocarcinoma of the Prostate by 68Ga-PSMA, 68Ga-FAPI, and 18F-FDG PET/CT

被引：4
|
作者：
Cai, Jiayu [1 ,2 ]
Xu, Weizhi [1 ,2 ]
Meng, Tinghua [1 ,2 ]
Pang, YiZhen [1 ,2 ]
Chen, Haojun [1 ,2 ,3 ]
机构：
[1] Xiamen Univ, Affiliated Hosp 1, Xiamen Canc Ctr, Sch Med,Dept Nucl Med, Xiamen, Peoples R China
[2] Xiamen Univ, Affiliated Hosp 1, Minnan PET Ctr, Xiamen Canc Ctr,Sch Med, Xiamen, Peoples R China
[3] 55 Zhenhai Rd, Xiamen 361003, Peoples R China
来源：
CLINICAL NUCLEAR MEDICINE | 2023年 / 48卷 / 08期
基金：
中国国家自然科学基金;
关键词：
F-18-FDG; Ga-68-FAPI; Ga-68-PSMA; neuroendocrine adenocarcinoma; neuroendocrine prostate cancer; PET/CT;
D O I：
10.1097/RLU.0000000000004719
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
Mixed neuroendocrine carcinoma-acinar carcinoma is an uncommon histological type of neuroendocrine prostate cancer. It has been rarely reported in de novo prostate malignancies. In this case, we present Ga-68-PSMA (prostate-specific membrane antigen), Ga-68-FAPI, and F-18-FDG PET/CT findings in the de novo form of mixed large-cell neuroendocrine carcinoma-acinar adenocarcinoma of the prostate. Different levels of radiotracer uptake were observed in different metastatic sites on Ga-68-PSMA, Ga-68-FAPI, and F-18-FDG PET/CT. This case demonstrates that the multitracer PET/CT strategy may be used for the noninvasive detection of the intermetastatic heterogeneity in metastatic neuroendocrine prostate cancer.
引用
收藏
页码：743 / 745
页数：3
相关论文
共 50 条
  • [31] Comparison of 18F-FDG and 68Ga-FAPI PET/CT in a Patient With Hepatic Perivascular Epithelioid Cell Neoplasm
    Li, Zhuoyuan
    Su, Dan
    Zhou, Sihui
    Wang, Yudi
    Chen, Yue
    CLINICAL NUCLEAR MEDICINE, 2023, 48 (12) : 1124 - 1126
  • [32] 68Ga-FAPI and 18F-FDG PET/CT Findings in a Patient With Pancreatic Tuberculosis Mimicking Malignant Tumor
    Sun, Rui
    Huang, Zhanwen
    Wei, Jing
    Zeng, Chengrun
    Chen, XiaoLiang
    CLINICAL NUCLEAR MEDICINE, 2022, 47 (07) : 653 - 654
  • [33] 68Ga-FAPI and 18F-FDG PET/CT Images in a Patient With Extrapulmonary Tuberculosis Mimicking Malignant Tumor
    Gu, Bingxin
    Luo, Zhiguo
    He, Xinhong
    Wang, Jian
    Song, Shaoli
    CLINICAL NUCLEAR MEDICINE, 2020, 45 (11) : 865 - 867
  • [34] Uncommon Metastases From Occult Breast Cancer Revealed by 18F-FDG and 68Ga-FAPI PET/CT
    Xu, Weizhi
    Meng, Tinghua
    Shang, Qihang
    Pang, Yizhen
    Chen, Haojun
    CLINICAL NUCLEAR MEDICINE, 2022, 47 (08) : 751 - 753
  • [35] Comparison of the diagnostic value of 68Ga-FAPI and 18F-FDG PET/CT in breast cancer: a systematic review
    Zhang, Jiayu
    Xiong, Jie
    Wang, Min
    Wu, Bin
    Zhang, Chunyin
    CLINICAL AND TRANSLATIONAL IMAGING, 2024, 12 (06) : 787 - 798
  • [36] 68Ga-FAPI and 18F-FDG Uptake in a Patient With Esophageal Candida Infection
    Chen, Xi
    Liu, Mengna
    Yang, Liping
    Shu, Qiaoqiao
    Cai, Liang
    CLINICAL NUCLEAR MEDICINE, 2024, 49 (01) : 83 - 85
  • [37] 68Ga-FAPI PET/CT Versus 68Ga-DOTATATE PET/CT in the Evaluation of a Patient With Neuroendocrine Tumor
    Komek, Halil
    Gundogan, Cihan
    Can, Canan
    CLINICAL NUCLEAR MEDICINE, 2021, 46 (05) : E290 - E292
  • [38] A Case with 68Ga-FAPI Positive and 18F-FDG Negative Breast Cancer
    Komek, Halil
    Gundogan, Cihan
    Etem, Hulya
    Can, Canan
    MOLECULAR IMAGING AND RADIONUCLIDE THERAPY, 2021, 30 (03) : 201 - 204
  • [39] 68Ga-FAPI-04 PET/CT for the Evaluation of Cholangiocarcinoma: Comparison With 18F-FDG PET/CT and Abdominal 68Ga-FAPI-04 PET/MR
    Zhang, Zeyu
    Cheng, Chao
    Jiang, Hui
    Pan, Guixia
    Yu, Yong
    Jin, Gang
    Zuo, Changjing
    CLINICAL NUCLEAR MEDICINE, 2024, 49 (05) : 409 - 418
  • [40] Recurrent Immunoglobulin G4-Related Disease Shown on 18F-FDG and 68Ga-FAPI PET/CT
    Pan, Qingqing
    Luo, Yaping
    Zhang, Wen
    CLINICAL NUCLEAR MEDICINE, 2020, 45 (04) : 312 - 313
12345